Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Chemicals Industry Analysis

UpdatedJul 23, 2026
DataAggregated Company Financials
Companies5
  • 7D-0.6%
  • 3M13.5%
  • 1Y-8.6%
  • YTD10.2%

Over the last 7 days, the Chemicals industry has remained flat. As for the longer term, the industry has declined 8.0% in the last year. Earnings are forecast to grow by 8.3% annually.

Industry Valuation and Performance

Has the Swiss Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 23 Jul 2026CHF 77.3bCHF 24.9bCHF 2.4b29.2x31.6x3.1x
Sat, 20 Jun 2026CHF 75.5bCHF 24.9bCHF 2.4b28x30.9x3x
Mon, 18 May 2026CHF 65.2bCHF 24.9bCHF 2.4b23.3x26.7x2.6x
Wed, 15 Apr 2026CHF 68.6bCHF 24.9bCHF 2.4b24.7x28.1x2.8x
Fri, 13 Mar 2026CHF 65.1bCHF 24.9bCHF 2.4b24x26.6x2.6x
Sun, 08 Feb 2026CHF 70.8bCHF 25.3bCHF 2.7b25.3x25.8x2.8x
Tue, 06 Jan 2026CHF 70.2bCHF 25.4bCHF 2.8b24.1x25.4x2.8x
Thu, 04 Dec 2025CHF 70.6bCHF 25.4bCHF 2.8b24.2x25.5x2.8x
Sat, 01 Nov 2025CHF 71.0bCHF 25.4bCHF 2.8b24.5x25.6x2.8x
Mon, 29 Sep 2025CHF 73.1bCHF 25.6bCHF 2.8b24.9x26.1x2.9x
Wed, 27 Aug 2025CHF 78.9bCHF 25.7bCHF 2.8b26.7x28.2x3.1x
Fri, 25 Jul 2025CHF 84.9bCHF 26.0bCHF 3.0b28.5x28.1x3.3x
Sun, 22 Jun 2025CHF 87.4bCHF 25.8bCHF 3.0b28.6x29x3.4x
Tue, 20 May 2025CHF 91.1bCHF 25.8bCHF 3.0b29.9x30.3x3.5x
Thu, 17 Apr 2025CHF 82.3bCHF 25.8bCHF 3.0b27.2x27.3x3.2x
Sat, 15 Mar 2025CHF 92.9bCHF 25.8bCHF 3.0b31.4x30.8x3.6x
Mon, 10 Feb 2025CHF 90.9bCHF 25.8bCHF 2.9b31.7x31.1x3.5x
Wed, 08 Jan 2025CHF 88.8bCHF 25.5bCHF 2.9b31.7x31.1x3.5x
Fri, 06 Dec 2024CHF 91.7bCHF 25.5bCHF 2.9b31.9x32.1x3.6x
Sun, 03 Nov 2024CHF 97.0bCHF 25.5bCHF 2.9b34.3x33.9x3.8x
Tue, 01 Oct 2024CHF 108.7bCHF 25.6bCHF 2.8b36x38.2x4.2x
Thu, 29 Aug 2024CHF 104.0bCHF 25.7bCHF 2.8b36.3x36.6x4.1x
Sat, 27 Jul 2024CHF 102.7bCHF 25.4bCHF 2.7b37.1x37.7x4x
Mon, 24 Jun 2024CHF 102.9bCHF 25.2bCHF 2.6b37.8x39.7x4.1x
Wed, 22 May 2024CHF 107.1bCHF 25.2bCHF 2.6b39.1x41.4x4.2x
Fri, 19 Apr 2024CHF 98.7bCHF 25.2bCHF 2.5b37.9x39.7x3.9x
Sun, 17 Mar 2024CHF 98.6bCHF 25.2bCHF 2.5b39.8x39.5x3.9x
Tue, 13 Feb 2024CHF 91.4bCHF 25.5bCHF 2.2b37.3x42x3.6x
Thu, 11 Jan 2024CHF 93.0bCHF 26.1bCHF 2.3b35.5x41.1x3.6x
Sat, 09 Dec 2023CHF 93.6bCHF 26.1bCHF 2.3b35.4x41.3x3.6x
Mon, 06 Nov 2023CHF 86.6bCHF 26.1bCHF 2.3b32.1x38.2x3.3x
Wed, 04 Oct 2023CHF 85.0bCHF 25.7bCHF 2.2b32.3x38.1x3.3x
Fri, 01 Sep 2023CHF 89.6bCHF 25.8bCHF 2.3b33.1x39.5x3.5x
Sun, 30 Jul 2023CHF 94.5bCHF 25.7bCHF 2.5b36x37.6x3.7x
Price to Earnings Ratio

37.6x


Total Market Cap: CHF 94.5bTotal Earnings: CHF 2.5bTotal Revenue: CHF 25.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Chemicals Industry Price to Earnings3Y Average 33x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 33.0x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Chemicals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Swiss Materials industry?

CH Market-0.21%
Materials-0.99%
Chemicals-0.62%
Specialty Chemicals-0.62%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry, which is trading close to its 3-year average PE ratio of 33.0x.
    • Analysts are expecting annual earnings growth of 8.3%, which is higher than its past year's earnings decline of 1.7% per year.
  • Investors are most pessimistic about the Specialty Chemicals industry, which is trading close to its 3-year average of 33.0x.
Forecasted Growth
  • Analysts are most optimistic on the Specialty Chemicals industry, expecting annual earnings growth of 8.3% over the next 5 years.
  • This is better than its past earnings decline of 1.7% per year.
  • In contrast, the Specialty Chemicals industry is expected to see its earnings grow by 8.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EMSN EMS-CHEMIE HOLDINGCHF 781.502.5%
+CHF 444.4m		20.1%PE39.2x

Latest News

CLN
CHF 7.28
Clariant
7D
-7.0%
1Y
-18.0%
GURN
CHF 36.00
Gurit Holding
7D
-1.6%
1Y
139.7%
Narrative Update • Jul 20

nan

Analysts have raised their price target for Gurit Holding from CHF 13.00 to CHF 20.00, reflecting updated assumptions regarding revenue growth, profit margins, the discount rate and future P/E levels. What's in the News for Gurit Holding No recent company specific news items were identified from the provided sources for Gurit Holding.
EMSN
CHF 781.50
EMS-CHEMIE HOLDING
7D
2.5%
1Y
20.1%
SIKA
CHF 157.60
Sika
7D
-2.6%
1Y
-22.9%
Narrative Update • Jul 08

SIKA: Neutral Rating Shift And Facility Expansion May Support Repricing

Analysts have nudged the fair value estimate for Sika higher, from CHF 180.69 to CHF 187.82. They cite slightly firmer revenue growth assumptions, a marginally lower discount rate, and updated P/E expectations that reflect the recent series of price target increases to around CHF 161 to CHF 165 alongside the shift to more neutral ratings.
GIVN
CHF 3,383.00
Givaudan
7D
-0.2%
1Y
-7.2%
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.